Catalyst Clinical Research

Catalyst Clinical Research provides highly customizable clinical trial management solutions to global biopharmaceutical and biotechnology companies. They are recognized for excellence in clinical trial management with a focus on oncology through their "Catalyst Oncology" division and multi-specialty functional services via "Catalyst Flex". The company has enabled sponsors to exceed enrollment goals and achieve promising endpoints leading to regulatory designations such as Breakthrough Therapy Designation. As a service provider/CRO rather than a drug developer, they do not have their own pipeline or proprietary clinical results. They have won industry awards such as the Fierce CRO Award for Excellence in Clinical Trial Management in 2025. Their flexible model allows them to support innovative therapies across many disease areas. No direct pipeline of drugs or programs owned by the company.